We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Maintains Lead in Cancer Drug Approvals, New Study Finds
FDA Maintains Lead in Cancer Drug Approvals, New Study Finds
September 7, 2012
The FDA continues to approve cancer drugs more quickly than the European Medicines Agency (EMA), clearing them in about half of the time regardless of the drugs’ designation, according to a recent study.